Welcome to LookChem.com Sign In|Join Free

CAS

  • or
16-Dehydropregnenolone acetate is a dehydration product of pregnenolone acetate, an off-white solid with unique chemical properties. It serves as a key intermediate in the synthesis of various pregnane derivatives and their glycosides, which have potential applications in the development of anticancer agents.

979-02-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 979-02-2 Structure
  • Basic information

    1. Product Name: 16-Dehydropregnenolone acetate
    2. Synonyms: (17-ACETYL-10,13-DIMETHYL-2,3,4,7,8,9,11,12,14,15-DECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-3-YL) ACETATE;16-DPA;16-DEHYDRO PREGNENLONE ACETATE;16-DEHYDROPREGNENOLONE ACETATE;5,16-Pregnadien-3b-ol-20-one acetate;5,16-PREGNADIEN-3B-ACETOXY-20-ONE;5,16-PREGNADIEN-3BETA-OL-20-ONE ACETATE;3b-Acetoxy-5,16-pregnadien-20-one
    3. CAS NO:979-02-2
    4. Molecular Formula: C23H32O3
    5. Molecular Weight: 356.5
    6. EINECS: 213-558-7
    7. Product Categories: Steroids;Steroid and Hormone
    8. Mol File: 979-02-2.mol
  • Chemical Properties

    1. Melting Point: 170-178°C
    2. Boiling Point: 464.4 °C at 760mmHg
    3. Flash Point: 200.1 °C
    4. Appearance: /
    5. Density: 1.11g/cm3
    6. Vapor Pressure: 8.38E-09mmHg at 25°C
    7. Refractive Index: 1.546
    8. Storage Temp.: Sealed in dry,Room Temperature
    9. Solubility: N/A
    10. CAS DataBase Reference: 16-Dehydropregnenolone acetate(CAS DataBase Reference)
    11. NIST Chemistry Reference: 16-Dehydropregnenolone acetate(979-02-2)
    12. EPA Substance Registry System: 16-Dehydropregnenolone acetate(979-02-2)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-37/39
    4. WGK Germany: 2
    5. RTECS: TU4156200
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 979-02-2(Hazardous Substances Data)

979-02-2 Usage

Uses

Used in Pharmaceutical Industry:
16-Dehydropregnenolone acetate is used as a precursor in the synthesis of pregnane derivatives and their glycosides for their potential anticancer properties. These compounds are being investigated for their ability to target and inhibit the growth of cancer cells, offering a promising avenue for the development of novel cancer therapies.

Check Digit Verification of cas no

The CAS Registry Mumber 979-02-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 9,7 and 9 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 979-02:
(5*9)+(4*7)+(3*9)+(2*0)+(1*2)=102
102 % 10 = 2
So 979-02-2 is a valid CAS Registry Number.
InChI:InChI=1/C23H32O3/c1-14(24)19-7-8-20-18-6-5-16-13-17(26-15(2)25)9-11-22(16,3)21(18)10-12-23(19,20)4/h5,7,17-18,20-21H,6,8-13H2,1-4H3/t17-,18-,20-,21-,22-,23+/m0/s1

979-02-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (D4687)  16-Dehydropregnenolone Acetate  >98.0%(HPLC)

  • 979-02-2

  • 5g

  • 560.00CNY

  • Detail
  • TCI America

  • (D4687)  16-Dehydropregnenolone Acetate  >98.0%(HPLC)

  • 979-02-2

  • 25g

  • 1,490.00CNY

  • Detail

979-02-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 16-Dehydropregenolone Acetate

1.2 Other means of identification

Product number -
Other names 16-Dehydropregnenolone acetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:979-02-2 SDS

979-02-2Synthetic route

3β-acetoxy-20-hydroxyiminopregna-5,16-diene
23549-24-8, 23549-26-0, 2174-13-2

3β-acetoxy-20-hydroxyiminopregna-5,16-diene

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
With Dess-Martin periodane In dichloromethane; water for 0.333333h;95%
(3β)-21-bromo-20-oxopregna-5,16-dien-3-yl acetate
86284-34-6

(3β)-21-bromo-20-oxopregna-5,16-dien-3-yl acetate

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
With aluminum oxide; zirconium(IV) chloride; benzaldehyde microwave irradiation;88%
3β-acetoxyandrosta-5,16-dien-17-yl trifluoromethanesulphonate
115375-60-5

3β-acetoxyandrosta-5,16-dien-17-yl trifluoromethanesulphonate

ethyl vinyl ether
109-92-2

ethyl vinyl ether

A

(Z/E)-3β-Acetoxypregna-5,17(20)-dien-21-al
16934-48-8

(Z/E)-3β-Acetoxypregna-5,17(20)-dien-21-al

B

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
With tetrakis(triphenylphosphine) palladium(0); triethylamine In dimethyl sulfoxide at 60℃; for 4h;A 8%
B 82%
Tributyl-[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-3-(tetrahydro-pyran-2-yloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-stannane
136321-38-5

Tributyl-[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-3-(tetrahydro-pyran-2-yloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-stannane

acetyl chloride
75-36-5

acetyl chloride

A

3β-acetoxyandrost-5,16-diene
1236-14-2

3β-acetoxyandrost-5,16-diene

B

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
With N,N,N,N,N,N-hexamethylphosphoric triamide; bis(benzonitrile)palladium(II) dichloride at 80℃; for 8h;A 80%
B 30%
3β,17α-diacetoxypregn-5-en-20-one
3517-38-2

3β,17α-diacetoxypregn-5-en-20-one

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
80%
acetic acid
64-19-7

acetic acid

solasodine
126-17-0

solasodine

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
Stage #1: solasodine With pyridine; ammonium chloride at 125 - 135℃; for 8 - 9h;
Stage #2: acetic acid With chromium(VI) oxide In water; 1,2-dichloro-ethane at 0 - 20℃; for 1h; Product distribution / selectivity;
65%
pseudodiosgenin diacetate
2309-38-8

pseudodiosgenin diacetate

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
With chromium(VI) oxide; acetic acid41%
Stage #1: pseudodiosgenin diacetate With potassium permanganate; sodium perchlorate In dichloromethane; water for 0.05h;
Stage #2: N-benzyl-N,N,N-triethylammonium chloride In dichloromethane; water at 20℃; for 6h;
Stage #3: With acetic acid for 3h; Product distribution / selectivity; Heating / reflux;
32%
Stage #1: pseudodiosgenin diacetate With potassium permanganate; sodium iodate In dichloromethane; water for 0.05h;
Stage #2: N-benzyl-N,N,N-triethylammonium chloride In dichloromethane; water at 20℃; for 10h;
Stage #3: With acetic acid for 3h; Product distribution / selectivity; Heating / reflux;
32%
3',4',6'-tri-O-acetyl-1',2',O-(16-dehydropregnenolone-3-yloxyethylidene)-α-D-glucopyranose
58026-06-5

3',4',6'-tri-O-acetyl-1',2',O-(16-dehydropregnenolone-3-yloxyethylidene)-α-D-glucopyranose

A

16-dehydropregnenolone
1162-53-4

16-dehydropregnenolone

B

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

C

di-16-dehydropregnenolone-2-yl ether
93238-36-9

di-16-dehydropregnenolone-2-yl ether

D

3-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-16-dehydropregnanolone
13407-28-8

3-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-16-dehydropregnanolone

E

3-O-(2',3',4',6'-tetra-O-acetyl-α-D-glucopyranosyl)-16-dehydropregnenolone
93269-28-4

3-O-(2',3',4',6'-tetra-O-acetyl-α-D-glucopyranosyl)-16-dehydropregnenolone

Conditions
ConditionsYield
With mercury dibromide In nitromethane at 90℃; for 1h; Product distribution; other molar ratio, other time;A 2%
B 8%
C 14%
D 36.3%
E 4%
3',4',6'-tri-O-acetyl-1',2',O-(16-dehydropregnenolone-3-yloxyethylidene)-α-D-glucopyranose
58026-06-5

3',4',6'-tri-O-acetyl-1',2',O-(16-dehydropregnenolone-3-yloxyethylidene)-α-D-glucopyranose

A

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

B

di-16-dehydropregnenolone-2-yl ether
93238-36-9

di-16-dehydropregnenolone-2-yl ether

C

3-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-16-dehydropregnanolone
13407-28-8

3-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-16-dehydropregnanolone

D

3-O-(2',3',4',6'-tetra-O-acetyl-α-D-glucopyranosyl)-16-dehydropregnenolone
93269-28-4

3-O-(2',3',4',6'-tetra-O-acetyl-α-D-glucopyranosyl)-16-dehydropregnenolone

Conditions
ConditionsYield
With mercury dibromide In nitromethane at 90℃; for 1h; Further byproducts given;A 8%
B 14%
C 36.3%
D 4%
(25R)-22,26-epiminocholesta-5,22(N)-diene-3β,16β-diol diacetate
30040-85-8

(25R)-22,26-epiminocholesta-5,22(N)-diene-3β,16β-diol diacetate

A

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

B

(20S)-3β,16β-diacetoxy-20-(5-methyl-2-pyridyl)pregn-5-ene

(20S)-3β,16β-diacetoxy-20-(5-methyl-2-pyridyl)pregn-5-ene

C

(25R)-3β,16β-diacetoxy-22,26-epiminocholest-5,22(N)-dien-23-one

(25R)-3β,16β-diacetoxy-22,26-epiminocholest-5,22(N)-dien-23-one

Conditions
ConditionsYield
With manganese(IV) oxide In chloroform for 48h; Ambient temperature;A 5%
B 6%
C 16%
3β-acetoxy-17-bromo-pregn-5-en-20-one
7391-03-9

3β-acetoxy-17-bromo-pregn-5-en-20-one

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
With 2,4,6-trimethyl-pyridine
Pregna-5,16-diene-20-yne-3β-ol 3-Acetate
52310-78-8

Pregna-5,16-diene-20-yne-3β-ol 3-Acetate

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
With boron trifluoride diethyl etherate; acetic anhydride; mercury(II) oxide Reagens 4: Essigsaeure;und anschliessend mit Wasser;
With water; aniline; mercury(II) chloride Reagens 4: Benzol;
3β-acetoxy-17-benzoyloxy-17βH-pregnen-(5)-one-(20)

3β-acetoxy-17-benzoyloxy-17βH-pregnen-(5)-one-(20)

A

pregna-3,5,16-trien-20-one
6795-58-0

pregna-3,5,16-trien-20-one

B

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
at 220℃; und anschliessend unter 10 Torr auf 300grad;
16-dehydropregnenolone
1162-53-4

16-dehydropregnenolone

acetic anhydride
108-24-7

acetic anhydride

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
With pyridine
acetic acid
64-19-7

acetic acid

(22R,25R)-28-acetyl-spirosol-5-en-3β-ol
58822-29-0

(22R,25R)-28-acetyl-spirosol-5-en-3β-ol

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
anschliessendes Behandeln mit CrO3 in wss. Essigsaeure und Erhitzen der danach erhaltenen Reaktionsloesung auf Siedetemperatur;
acetic acid
64-19-7

acetic acid

solasodine N,O-diacetate
4860-15-5

solasodine N,O-diacetate

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
anschliessendes Behandeln mit CrO3 in wss. Essigsaeure und Erhitzen der danach erhaltenen Reaktionsloesung auf Siedetemperatur;
acetic anhydride
108-24-7

acetic anhydride

solasodine
126-17-0

solasodine

A

3β-acetoxy-16α-methoxy-pregn-5-en-20-one
55320-51-9

3β-acetoxy-16α-methoxy-pregn-5-en-20-one

B

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
Behandeln mit CrO3 in wss. Essigsaeure, Erwaermen mit methanol. KOH und Behandeln mit Acetanhydrid und Pyridin;
Acetic acid (3S,8R,9S,10R,13S,14S,16R,17S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-20-oxa-cyclopropa[16,17]cyclopenta[a]phenanthren-3-yl ester
34209-81-9

Acetic acid (3S,8R,9S,10R,13S,14S,16R,17S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-20-oxa-cyclopropa[16,17]cyclopenta[a]phenanthren-3-yl ester

A

3β-acetoxy-16α-hydroxy-pregn-5-en-20-one
4059-78-3

3β-acetoxy-16α-hydroxy-pregn-5-en-20-one

B

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
With chromium dichloride
acetic anhydride
108-24-7

acetic anhydride

Acetic acid (3S,8R,9S,10R,13S,14S)-17-(1-acetylamino-vinyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Acetic acid (3S,8R,9S,10R,13S,14S)-17-(1-acetylamino-vinyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
With dmap In dichloromethane Heating; Yield given;
16-dehydro-pregnenolone acetate ethylene ketal
39932-37-1

16-dehydro-pregnenolone acetate ethylene ketal

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
With aluminium(III) iodide In acetonitrile; benzene for 0.25h; Ambient temperature;85 % Chromat.
diosgenin
512-04-9

diosgenin

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Conditions
ConditionsYield
Yield given. Multistep reaction;
Multi-step reaction with 3 steps
1: 1 h / 195 °C
2: CrO3; AcOH / 3 h / 10 - 15 °C
3: 2.3 g / sodium bisulphite; AcOH / H2O / 1 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: boron trifluoride diethyl etherate / dichloromethane
2: acetic acid; chromium(VI) oxide / dichloromethane
View Scheme
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Pregnenolone acetate
1778-02-5

Pregnenolone acetate

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethyl acetate at 30℃; under 2327.2 Torr; for 16h;98%
With ammonium formate; palladium on activated charcoal In methanol for 0.6h; Heating;98%
With hydrogen; palladium on activated charcoal In ethyl acetate at 30℃; under 2327.23 Torr; for 12h;98%
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

3β-hydroxypregn-5-en-20-one-3-acetate
1093959-59-1

3β-hydroxypregn-5-en-20-one-3-acetate

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In ethyl acetate at 30℃; for 6h;98.18%
With magnesium; zinc(II) chloride for 0.583333h;90%
With hydrogen; Cu/Al2O3 under 760 Torr;87%
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

3β-acetoxy-5α,6α-epoxypregn-16-ene-20-one
14279-42-6

3β-acetoxy-5α,6α-epoxypregn-16-ene-20-one

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 20℃; for 1h;98%
With 3-chloro-benzenecarboperoxoic acid In chloroform at 20℃; for 0.5h;97%
With 3-chloro-benzenecarboperoxoic acid In chloroform at 20℃; for 0.5h;97%
With silica gel; 3-chloro-benzenecarboperoxoic acid at 20℃; for 1.5h;91.75%
With 3-chloro-benzenecarboperoxoic acid In chloroform at 0 - 20℃;
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

pregnenolone acetate
906-83-2

pregnenolone acetate

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethanol at 30℃; under 2844.39 Torr; for 12h;98%
With 5% Pd(II)/C(eggshell); hydrogen In ethanol under 2327.23 Torr; for 10h;95%
With 5%-palladium/activated carbon; hydrogen In ethanol under 2327.23 Torr; for 12h;95%
Multi-step reaction with 2 steps
1: hydrogen; 5%-palladium/activated carbon / ethyl acetate / 20 °C / 750.08 Torr
2: hydrogen; palladium 10% on activated carbon / ethyl acetate / 20 °C / 750.08 Torr
View Scheme
N-hydroxy-4-methylbenzenecarboximidoyl chloride
36288-37-6

N-hydroxy-4-methylbenzenecarboximidoyl chloride

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

3β-acetoxy-3'-4

3β-acetoxy-3'-4"-tolyl-2'-isoxazolino[4',5'-d:16α,17α]pregn-5-en-20-one

Conditions
ConditionsYield
Stage #1: N-hydroxy-4-methylbenzenecarboximidoyl chloride; 16-dehydropregnenolone acetate With N-ethyl-N,N-diisopropylamine In toluene at 20℃; for 0.0833333h;
Stage #2: In toluene at 111℃; for 2h; regioselective reaction;
98%
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

3β-hydroxy-16α,17α-epoxypregn-5-en-20-one
974-23-2

3β-hydroxy-16α,17α-epoxypregn-5-en-20-one

Conditions
ConditionsYield
With sodium hydroxide; urea hydrogen peroxide adduct In methanol; water at 5℃; for 72h;97%
With sodium hydroxide; urea hydrogen peroxide adduct In methanol; water at 5 - 500℃; for 72h;97%
With sodium hydroxide; dihydrogen peroxide In methanol; water at 5 - 15℃; for 23h;95%
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

16-dehydropregnenolone
1162-53-4

16-dehydropregnenolone

Conditions
ConditionsYield
With water; sodium hydroxide In methanol at 20℃; for 12h; Reagent/catalyst; Solvent;97%
With potassium hydroxide; tert-butyl alcohol In water at 30℃; for 10h;96%
With potassium hydroxide In tert-butyl alcohol at 30℃; for 10h;96%
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

3β-acetoxy-20-hydroxyiminopregna-5,16-diene
23549-24-8, 23549-26-0, 2174-13-2

3β-acetoxy-20-hydroxyiminopregna-5,16-diene

Conditions
ConditionsYield
With pyridine; hydroxylamine hydrochloride In ethanol for 0.5h; Reflux;97%
With pyridine; hydroxylamine hydrochloride In ethanol for 0.5h; Reflux;97%
With pyridine; hydroxylamine hydrochloride for 96h; Cooling;96%
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

N-hydroxy-4-methoxy-benzenecarboximidoyl chloride
38435-51-7

N-hydroxy-4-methoxy-benzenecarboximidoyl chloride

3β-acetoxy-3'-4

3β-acetoxy-3'-4"-methoxyphenyl-2'-isoxazolino[4',5'-d:16α,17α]pregn-5-en-20-one

Conditions
ConditionsYield
Stage #1: 16-dehydropregnenolone acetate; N-hydroxy-4-methoxy-benzenecarboximidoyl chloride With N-ethyl-N,N-diisopropylamine In toluene at 20℃; for 0.0833333h;
Stage #2: In toluene at 111℃; for 2h; regioselective reaction;
97%
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

(3β)-21-bromo-20-oxopregna-5,16-dien-3-yl acetate
86284-34-6

(3β)-21-bromo-20-oxopregna-5,16-dien-3-yl acetate

Conditions
ConditionsYield
With t-butyldimethylsiyl triflate; bromine; triethylamine In dichloromethane95%
With copper(ll) bromide In i-Amyl alcohol at 46 - 48℃;95%
With copper(ll) bromide In tetrahydrofuran
t-butyldimethylsiyl triflate
69739-34-0

t-butyldimethylsiyl triflate

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

3β-Acetoxy-20-(tert-butyldimethylsilyl)oxypregna-5,16,20-triene

3β-Acetoxy-20-(tert-butyldimethylsilyl)oxypregna-5,16,20-triene

Conditions
ConditionsYield
With triethylamine In diethyl ether at 0 - 20℃; for 0.75h;95%
With triethylamine In dichloromethane at 5℃;82%
acetyl hydrazine hydrochloride
36147-94-1

acetyl hydrazine hydrochloride

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

1'-acetyl-3'-methyl-3β-acetoxyandrost-5-eno[17,16-d]pyrazole

1'-acetyl-3'-methyl-3β-acetoxyandrost-5-eno[17,16-d]pyrazole

Conditions
ConditionsYield
With iodine In ethanol for 1h; Cycloaddition; Heating;95%
methylmagnesium bromide
75-16-1

methylmagnesium bromide

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

16α-methylpregn-5-en-3β-ol-20-one 3-acetate
1863-41-8

16α-methylpregn-5-en-3β-ol-20-one 3-acetate

Conditions
ConditionsYield
Stage #1: methylmagnesium bromide; 16-dehydropregnenolone acetate With copper(l) chloride In tetrahydrofuran at -10 - 0℃; for 0.333333h; Grignard reaction; Inert atmosphere;
Stage #2: With methanol In tetrahydrofuran at -5℃; for 0.25h;
Stage #3: With water In tetrahydrofuran; methanol at 5 - 10℃; for 2h;
95%
4-fluorophenyl benzaldehyde-tosylhydrazone sodium salt
107633-40-9

4-fluorophenyl benzaldehyde-tosylhydrazone sodium salt

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

3β-acetoxy-4',5'-dihydro-5'β-(4-fluorophenyl)pregn-5-eno[17α,16α-c]pyrazol-20-one

3β-acetoxy-4',5'-dihydro-5'β-(4-fluorophenyl)pregn-5-eno[17α,16α-c]pyrazol-20-one

Conditions
ConditionsYield
In methanol; dichloromethane at 175℃; under 0.05 Torr;95%
sodium 2-benzylidene-1-tosylhydrazin-1-ide
27992-27-4, 40154-38-9

sodium 2-benzylidene-1-tosylhydrazin-1-ide

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

3β-acetoxy-4',5'-dihydro-5'β-phenylpregn-5-eno[17α,16α-c]pyrazol-20-one

3β-acetoxy-4',5'-dihydro-5'β-phenylpregn-5-eno[17α,16α-c]pyrazol-20-one

Conditions
ConditionsYield
In methanol; dichloromethane at 175℃; under 0.05 Torr;95%
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

benzohydroximoyl chloride
698-16-8

benzohydroximoyl chloride

3β-acetoxy-3'-phenyl-2'-isoxazolino[4',5'-d:16α,17α]pregn-5-en-20-one
1062-66-4

3β-acetoxy-3'-phenyl-2'-isoxazolino[4',5'-d:16α,17α]pregn-5-en-20-one

Conditions
ConditionsYield
Stage #1: 16-dehydropregnenolone acetate; benzohydroximoyl chloride With N-ethyl-N,N-diisopropylamine In toluene at 20℃; for 0.0833333h;
Stage #2: In toluene at 111℃; for 2h; regioselective reaction;
95%
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

3β-hydroxy-16β-chloropregn-5-en-20-one

3β-hydroxy-16β-chloropregn-5-en-20-one

Conditions
ConditionsYield
With hydrogenchloride In methanol94%
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

C23H32O5

C23H32O5

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In chloroform for 3h; Reflux;93.54%
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

Pregnenolone
145-13-1

Pregnenolone

Conditions
ConditionsYield
Stage #1: 16-dehydropregnenolone acetate With hydrogen at 0 - 25℃; for 1h;
Stage #2: With potassium hydroxide for 2h; Reflux;
92.8%
Multi-step reaction with 2 steps
1: 98 percent / H2 / Pd/C / ethyl acetate / 12 h / 30 °C / 2327.23 Torr
2: 97 percent / potassium hydroxide; H2O / methanol / 2 h / 30 °C
View Scheme
Multi-step reaction with 2 steps
1: 97 percent / H2 / Pd/C / 15 h / 30 °C / 2327.17 Torr
2: 96 percent / KOH / 2-methyl-propan-2-ol; H2O / 16 h / 30 °C
View Scheme
pyridine
110-86-1

pyridine

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

1-[2-((3S,8R,9S,10R,13S,14S)-3-Acetoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl]-pyridinium; iodide

1-[2-((3S,8R,9S,10R,13S,14S)-3-Acetoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl]-pyridinium; iodide

Conditions
ConditionsYield
With iodine for 2h; Heating;91.7%
trimethylsilyl cyanide
7677-24-9

trimethylsilyl cyanide

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

20-cyano-20-trimethylsilanyloxypregne-5,16-dien-3β-yl acetate

20-cyano-20-trimethylsilanyloxypregne-5,16-dien-3β-yl acetate

Conditions
ConditionsYield
With lithium ethoxide In tetrahydrofuran at 20℃;91%
Dimethyl oxalate
553-90-2

Dimethyl oxalate

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

3β-hydroxy-21-methoxalylpregna-5,16-dien-20-one

3β-hydroxy-21-methoxalylpregna-5,16-dien-20-one

Conditions
ConditionsYield
With pyridine; sodium methylate; sodium chloride for 1h;91%
nitromethane
75-52-5

nitromethane

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

3β-acetoxy-16α-nitromethyl-5-pregnan-20-one
117772-40-4

3β-acetoxy-16α-nitromethyl-5-pregnan-20-one

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In dichloromethane at 20℃; for 12h;90%
With piperidine
With 1,8-diazabicyclo[5.4.0]undec-7-ene In dichloromethane at 0℃; Michael condensation;
With 1,8-diazabicyclo[5.4.0]undec-7-ene In dichloromethane
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

allyl-trimethyl-silane
762-72-1

allyl-trimethyl-silane

3β-acetoxy-16α-prop-2'-enylpregn-5-en-20-one
54022-29-6

3β-acetoxy-16α-prop-2'-enylpregn-5-en-20-one

Conditions
ConditionsYield
With titanium tetrachloride In dichloromethane for 5h; Ambient temperature;90%
phenylhydrazine hydrochloride
59-88-1

phenylhydrazine hydrochloride

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

3-acetoxy-5'-methyl-2'-phenyl-2'H-androst-5-eno[16,17-c]pyrazole
32671-70-8

3-acetoxy-5'-methyl-2'-phenyl-2'H-androst-5-eno[16,17-c]pyrazole

Conditions
ConditionsYield
With iodine In ethanol for 1h; Cycloaddition; Heating;88%
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

α-bromoacetophenone
70-11-1

α-bromoacetophenone

malononitrile
109-77-3

malononitrile

16-(1',1'-dicyano-3'-phenyl-3'-oxo-propano)-pregnenolone-3-acetate

16-(1',1'-dicyano-3'-phenyl-3'-oxo-propano)-pregnenolone-3-acetate

Conditions
ConditionsYield
With potassium hydroxide In methanol at 15 - 20℃; for 0.5h; Michael addition;88%
methylmagnesium bromide
75-16-1

methylmagnesium bromide

16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

17α-hydroperoxy-16α-methyl-20-oxopregn-5-en-3β-yl acetate
115040-05-6

17α-hydroperoxy-16α-methyl-20-oxopregn-5-en-3β-yl acetate

Conditions
ConditionsYield
With copper(l) chloride In tetrahydrofuran; benzene at 0 - 5℃; for 0.333333h; Grignard reaction; Inert atmosphere;88%
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

3β-acetoxy-5α,6β-dichloropregn-16-en-20-one
68315-64-0

3β-acetoxy-5α,6β-dichloropregn-16-en-20-one

Conditions
ConditionsYield
With chloro-trimethyl-silane; tetradecyltrimethylammonium permanganate In dichloromethane at 0 - 3℃; for 1.5h;87%

979-02-2Relevant articles and documents

Crystal structure of 3β-acetoxy-pregna-5,16-dien-20-one (16 DPA)

Bandhoria, Pankaj,Gupta, Vivek K.,Gupta,Jain,Varghese

, p. 161 - 166 (2006)

The title compound, 3β-acetoxy-pregna-5,16-dien-20-one, C 23H32O3, has been synthesized by acetylation followed by oxidation of diosgenin and its crystal structure has been solved from single crystal X-ray diffraction data. The compound crystallizes into orthorhombic space group P212121 with unit cell parameters: a = 6.031(4) A, b = 12.481(2) A, c = 27.162(5) A, Z = 4. The crystal structure has been refined to R = 0.0597 for 1291 observed reflections. Rings A and C of the compound are in chair conformation whereas ring B is in half-chair conformation. Ring D is in envelop conformation. The A/B ring junction is quasi-trans, while ring systems B/C and C/D are trans fused about the C8-C9 and C13-C14 bonds, respectively. The steroid nucleus has a small twist, as shown by the C19-C10...C13-C18 pseudo-torsion angle of 9.5°. The crystal packing is determined by a pair of weak C-H...O hydrogen bonds in addition to van der Waals interactions.

Synthesis of silyl enol and silyl dienol ethers of 20-Oxosteroids: The effect of β-substituents

Moreno, Maria Jose S. M.,Martins, Rosa Maria L. M.,Sa E Melo, Maria Luisa,Campos Neves, Andre S.

, p. 529 - 530 (1997)

An efficient method to obtain regioselectively the title compounds is described. Experimental studies concerning the effect of β-substituents on the generation of β-substituted silyl enol ethers made feasible for the first time the isolation and identification of the products resulting from the unstable thermodynamic silyl enol ether.

Facile green synthesis of 16-dehydropregnenolone acetate (16-DPA) from diosgenin

Baruah, Diganta,Das, Ram Nath,Konwar, Dilip

, p. 79 - 84 (2016)

Chromium- and MnO2-free green synthesis of industrially important steroidal drug intermediate 16-dehydropregnenolone acetate (16-DPA) starting from diosgenin is reported. The reaction sequence involves three steps: acetolysis followed by acetylation, oxidation, and hydrolysis. In the first step, Ac2O was used both as reagent and solvent in combination with a Lewis acid (AlCl3), which led to considerable reduction of high temperature and pressure requirements of earlier processes. The oxidation step was made catalytic with the use of KMnO4(5 mol%) in the presence of co-oxidant NaIO4, leading to less waste generation (of chromium, MnO2, etc.). Minimization of the temperature, pressure, time consumption, and use of nontoxic solvents makes the process very handy and simple.

A Dual Role Reductase from Phytosterols Catabolism Enables the Efficient Production of Valuable Steroid Precursors

Peng, Haidong,Wang, Yaya,Jiang, Kai,Chen, Xinru,Zhang, Wenlu,Zhang, Yanan,Deng, Zixin,Qu, Xudong

supporting information, p. 5414 - 5420 (2021/02/05)

4-Androstenedione (4-AD) and progesterone (PG) are two of the most important precursors for synthesis of steroid drugs, however their current manufacturing processes suffer from low efficiency and severe environmental issues. In this study, we decipher a dual-role reductase (mnOpccR) in the phytosterols catabolism, which engages in two different metabolic branches to produce the key intermediate 20-hydroxymethyl pregn-4-ene-3-one (4-HBC) through a 4-e reduction of 3-oxo-4-pregnene-20-carboxyl-CoA (3-OPC-CoA) and 2-e reduction of 3-oxo-4-pregnene-20-carboxyl aldehyde (3-OPA), respectively. Inactivation or overexpression of mnOpccR in the Mycobacterium neoaurum can achieve exclusive production of either 4-AD or 4-HBC from phytosterols. By utilizing a two-step synthesis, 4-HBC can be efficiently converted into PG in a scalable manner (100 gram scale). This study deciphers a pivotal biosynthetic mechanism of phytosterol catabolism and provides very efficient production routes of 4-AD and PG.

Continuous Flow Synthesis of 16-Dehydropregnenolone Acetate, a Key Synthon for Natural Steroids and Drugs

Mancino, Valentina,Cerra, Bruno,Piccinno, Alessandro,Gioiello, Antimo

supporting information, p. 600 - 607 (2018/05/14)

A telescoped multistep process to provide the continuous delivery of 16-dehydropregnenolone acetate (16-DPA) from diosgenin is described. The method was evaluated through batch screenings that helped to identify critical bottlenecks and flowability, and the best conditions were optimized in flow systems before the individual steps were telescoped together into a single integrated flow process. Further highlights of our approach include the use of efficient in-line extraction operations and reaction monitoring, the avoidance of time-consuming purifications between steps, and improvement of efficiency and safety standards.

Some observations on solasodine reactivity

Jastrzebska, Izabella,Morzycki, Jacek W.

, p. 13 - 17 (2017/09/15)

This article presents new transformations of solasodine – a representative steroid alkaloid sapogenin from the Solanum family. Oxidation of N,O-diacetylated solasodine with either NaNO2/BF3·Et2O or t-BuONO/BF3·Et2O resulted in partial degradation of the side chain to (20S)-3β-acetoxypregn-5-ene-20,16β-carbolactone (vespertilin acetate). The same starting compound when treated with TMSOTf afforded the corresponding pseudosapogenin after aqueous work-up. However, when the crude reaction mixture was directly subjected to purification on a silica gel column, efficient autoxidation to pregna-5,16-dien-3β-ol-20-one acetate was observed. One-step synthesis of this important drug intermediate from spirosolan alkaloids may be potentially exploited for large-scale production of steroid hormones.

METHODS FOR PREPARATION OF BILE ACIDS AND DERIVATIVES THEREOF

-

Page/Page column 56, (2017/02/24)

The present application relates to a method of preparing compounds of Formula (I) or a pharmaceutically acceptable salt, solvate, or amino acid conjugate thereof, R1 is H, α-OH, β-ΟΗ, or an oxo group.

Microwave-assisted stereoselective approach to novel steroidal ring D-fused 2-pyrazolines and an evaluation of their cell-growth inhibitory effects in vitro

Mótyán, Gergo,Kovács, Ferenc,W?lfling, János,Gyovai, András,Zupkó, István,Frank, éva

, p. 36 - 46 (2016/05/24)

Novel ring D-condensed 2-pyrazolines in the Δ5-androstene series were efficiently synthesized from 16-dehydropregnenolone or its acetate with different arylhydrazines or methylhydrazine, respectively, under microwave irradiation. The reactions are assumed to occur via hydrazone intermediates, followed by intramolecular 1,4-addition leading to the fused heteroring stereoselectively with a 16α,17α-cis ring junction. The synthesized compounds were subjected to in vitro pharmacological studies of their antiproliferative activities against four human breast (MCF7, T47D, MDA-MB-231 and MDA-MB-361) and three cervical (HeLa, C33A and SiHA) malignant cell lines. Flow cytometry revealed that the most potent agent elicited a cell cycle disturbance.

Synthesis of steroidal derivatives containing substituted, fused and spiro pyrazolines

Romero-López, Anabel,Montiel-Smith, Sara,Meza-Reyes, Socorro,Merino-Montiel, Penélope,Vega-Baez, José Luis

, p. 86 - 92 (2014/07/08)

An efficient and facile synthesis of fused, substituted and spiro pyrazoline steroid derivatives through a cycloaddition reaction of different α,β-unsaturated ketones with hydrazine acetate in acetic acid is reported. Depending on the starting material, the ring closure reaction provided a mixture of two steroidal pyrazoline epimers that were separated and studied by NMR techniques. In one case it was possible to isolate and characterize the hydrazone derivative as the reaction intermediate, which confirms the mechanism proposed in the literature [11,25,26].2014 Published by Elsevier Inc.

Synthesis and characterization of new phenyl esters derived from 16-dehydropregnenolone acetate (16-DPA)

Li, Hongqi,Fang, Jueshu,Li, Juan,Wang, Yulong,Tian, Xiujuan,Xiang, Yuanhui

, p. 3887 - 3893 (2013/10/22)

A series of new phenyl esters based on a 5,16-pregnadiene-20-one skeleton, namely 3β-benzoyloxy-5,16-pregnadiene-20-ones, which may be good inhibitors of 17α-hydroxylase and 5α-reductase enzyme or useful intermediates for producing steroidal drugs, were synthesized starting from diosgenin. The structures of the steroids were characterized by 1H nuclear magnetic resonance (NMR), 13C NMR, infrared (IR), and mass spectra.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 979-02-2